transcription factors T-bet and GATA-3 control alternative pathways of T-cell differentiation through a shared set of target genes

Upon detection of antigen, CD4⁺ T helper (Th) cells can differentiate into a number of effector types that tailor the immune response to different pathogens. Alternative Th1 and Th2 cell fates are specified by the transcription factors T-bet and GATA-3, respectively. Only a handful of target genes a...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 106; no. 42; pp. 17876 - 17881
Main Authors Jenner, Richard G, Townsend, Michael J, Jackson, Ian, Sun, Kaiming, Bouwman, Russell D, Young, Richard A, Glimcher, Laurie H, Lord, Graham M
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 20.10.2009
National Acad Sciences
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Upon detection of antigen, CD4⁺ T helper (Th) cells can differentiate into a number of effector types that tailor the immune response to different pathogens. Alternative Th1 and Th2 cell fates are specified by the transcription factors T-bet and GATA-3, respectively. Only a handful of target genes are known for these two factors and because of this, the mechanism through which T-bet and GATA-3 induce differentiation toward alternative cell fates is not fully understood. Here, we provide a genomic map of T-bet and GATA-3 binding in primary human T cells and identify their target genes, most of which are previously unknown. In Th1 cells, T-bet associates with genes of diverse function, including those with roles in transcriptional regulation, chemotaxis and adhesion. GATA-3 occupies genes in both Th1 and Th2 cells and, unexpectedly, shares a large proportion of targets with T-bet. Re-complementation of T-bet alters the expression of these genes in a manner that mirrors their differential expression between Th1 and Th2 lineages. These data show that the choice between Th1 and Th2 lineage commitment is the result of the opposing action of T-bet and GATA-3 at a shared set of target genes and may provide a general paradigm for the interaction of lineage-specifying transcription factors.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
3Present address: Aileron Therapeutics, 840 Memorial Drive, Cambridge, MA 02139.
Author contributions: R.G.J., M.J.T., R.A.Y., L.H.G., and G.M.L. designed research; R.G.J., M.J.T., I.J., K.S., R.D.B., and G.M.L. performed research; R.J., K.S., and G.M.L. contributed new reagents/analytic tools; R.G.J., K.S., L.H.G., and G.M.L. analyzed data; and R.G.J., L.H.G., and G.M.L. wrote the paper.
2Present address: Genentech, Inc., Mail Stop No. 34, 1 DNA Way, South San Francisco, CA 94080.
Contributed by Laurie H. Glimcher, August 18, 2009
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.0909357106